University of Texas MD Anderson Cancer Center (Adults and Pediatrics)

Houston, Texas 77030

Use our guide to learn which trials are right for you!

We've found
3 trials
at this facility
Hematology, Immunology / Infectious Diseases, Oncology Clinical Trial
Expanded Access Protocol for Tabelecleucel in Subjects With EBV-Associated Viremia or Malignancies
Status: Enrolling, Phase
Updated: 12/31/1969
University of Texas MD Anderson Cancer Center (Adults and Pediatrics)
mi
from
Houston, TX
Click here to add this to my saved trials
Epstein-Barr Virus-Related Post-Transplant Lymphoproliferative Disorder Clinical Trial
Tabelecleucel for Solid Organ Transplant Subjects With EBV+ PTLD After Failure of Rituximab or Rituximab and Chemotherapy
Status: Enrolling, Phase III
Updated: 12/31/1969
University of Texas MD Anderson Cancer Center (Adults and Pediatrics)
mi
from
Houston, TX
Click here to add this to my saved trials
Epstein-Barr Virus-Related Post-Transplant Lymphoproliferative Disorder Clinical Trial
Tabelecleucel for Allogeneic Hematopoietic Cell Transplant Subjects With EBV+ PTLD After Failure of Rituximab
Status: Enrolling, Phase III
Updated: 12/31/1969
University of Texas MD Anderson Cancer Center (Adults and Pediatrics)
mi
from
Houston, TX
Click here to add this to my saved trials